A panel of experts review three clinical cases of hepatocellular carcinoma, highlighting individualized treatment approaches and key clinical trial data used to guide therapy.
Expert Perspective Tumor Board
Key opinion leaders review clinical cases in renal cell carcinoma, focusing on recent advances, treatment options, and clinical trials impacting treatment.
Key opinion leaders review clinical cases in thyroid cancer, focusing on recent advances, treatment options, and clinical trials impacting clinical practice.
Key opinion leaders review clinical cases in triple-negative breast cancer, focusing on recent advances, treatment options, and clinical trials impacting the treatment.
Experts in MPN review clinical cases of in polycythemia vera, myelofibrosis, and essential thrombocythemia.
Key opinion leaders review clinical cases in HER2-positive breast cancer, focusing on treatment options and clinical trials impacting treatment selection.
Experts in breast cancer review clinical cases, discuss individualized treatment options and key clinical trials.
Experts review 3 clinical cases, discuss treatment options and relevant clinical trials in GIST.
Experts in genitourinary cancer review 2 clinical cases and address major changes in the management of patients with castration-resistant prostate cancer.
Experts review clinical cases and best practices for managing relapsed/refractory DLBCL.
Experts in breast oncology review 3 clinical cases of HER2+ breast cancer and discuss individualized treatment approaches for each patient.
Experts in lung oncology review 3 clinical cases and discuss individualized treatment approaches for each patient.
Experts in stem cell transplantation review the background of graft-versus-host disease and discuss 3 clinical cases and individualized treatment approaches.
Experts in gynecological oncology review 3 clinical cases and best practices for various patients with newly diagnosed and recurrent ovarian cancer.
Experts in myeloproliferative neoplasms review 4 clinical cases and best practices for patients with, primary myelofibrosis, polycythemia vera, essential thrombocythemia, and blast transformation.
Experts in breast oncology review 4 clinical cases and discuss individualized treatment approaches for each patient.
Chronic Myeloid Leukemia
Advanced Ovarian Cancer
Management of Metastatic Colon Cancer
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Grants Traditional Approval to Pirtobrutinib in CLL/SLL
2
Safusidenib Shows Robust, Ongoing Responses in Grade 2 IDH1-Mutant Glioma
3
Sac-TMT Demonstrates Antitumor Activity, Safety in Urothelial Carcinoma
4
Durable Responses With Novel Cell Therapy TARA-002 in BCG-Naive NMIBC
5
